ARISAN, E. D. Et Al. 2017. Serotonin altered receptor tyrosine signalling pathway differently in MCF-7 and MDA-MB-231 breast cancer cells. The 22nd World Congress on Advances in Oncology and 20th International Symposium on Molecular Medicine , (Athens, Greece), 27.

ARISAN, E. D., İlkhan, D., ÖZFİLİZ KILBAŞ, P., ÇOKER GÜRKAN, A., OBAKAN YERLİKAYA, P., & ÜNSAL, Z. N., (2017). Serotonin altered receptor tyrosine signalling pathway differently in MCF-7 and MDA-MB-231 breast cancer cells . The 22nd World Congress on Advances in Oncology and 20th International Symposium on Molecular Medicine (pp.27). Athens, Greece

ARISAN, ELİF Et Al. "Serotonin altered receptor tyrosine signalling pathway differently in MCF-7 and MDA-MB-231 breast cancer cells," The 22nd World Congress on Advances in Oncology and 20th International Symposium on Molecular Medicine, Athens, Greece, 2017

ARISAN, ELİF D. Et Al. "Serotonin altered receptor tyrosine signalling pathway differently in MCF-7 and MDA-MB-231 breast cancer cells." The 22nd World Congress on Advances in Oncology and 20th International Symposium on Molecular Medicine , Athens, Greece, pp.27, 2017

ARISAN, E. D. Et Al. (2017) . "Serotonin altered receptor tyrosine signalling pathway differently in MCF-7 and MDA-MB-231 breast cancer cells." The 22nd World Congress on Advances in Oncology and 20th International Symposium on Molecular Medicine , Athens, Greece, p.27.

@conferencepaper{conferencepaper, author={ELİF DAMLA ARISAN Et Al. }, title={Serotonin altered receptor tyrosine signalling pathway differently in MCF-7 and MDA-MB-231 breast cancer cells}, congress name={The 22nd World Congress on Advances in Oncology and 20th International Symposium on Molecular Medicine}, city={Athens}, country={Greece}, year={2017}, pages={27} }